A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

September 17, 2020

Primary Completion Date

November 30, 2025

Study Completion Date

May 28, 2027

Conditions
Hematological Malignancies
Interventions
DRUG

Teclistamab

Teclistamab will be administered SC.

Trial Locations (51)

3000

Universitaire Ziekenhuizen Leuven, Leuven

9000

Universitair Ziekenhuis Gent - UZ GENT, Ghent

10029

Icahn School of Medicine at Mount Sinai Program for the Protection of Human Subjects, New York

10065

Memorial Sloan-Kettering Cancer Center, New York

19104

University of Pennsylvania, Philadelphia

20133

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

24127

Azienda Ospedaliera Papa Giovanni XXIII, Bergamo

28041

Hosp. Univ. 12 de Octubre, Madrid

28204

Levine Cancer Institute, Charlotte

28223

Hosp. Quiron Madrid Pozuelo, Pozuelo de Alarcón

30060

Tianjin Medical University Cancer Institute and Hospital, Tianjin

30322

Winship Cancer Institute Emory University, Atlanta

31008

Clinica Univ. de Navarra, Pamplona

31059

Pôle IUC Oncopole CHU, Toulouse

35294

University of Alabama at Birmingham, Birmingham

37007

Hosp Clinico Univ de Salamanca, Salamanca

37044

CHRU Hôpital Bretonneau, Tours

39008

Hosp. Univ. Marques de Valdecilla, Santander

40138

Istituto di Ematologia Seràgnoli azienda ospedaliera univeristaria Policlinico S.Orsola-Malpighi, Bologna

44093

C.H.U. Hotel Dieu - France, Nantes

48201

Barbara Ann Karmanos Cancer Institute, Detroit

59000

Centre Hospitalier Régional Universitaire de Lille, Hôpital Claude Huriez, Lille

69120

Universitaetsklinikum Heidelberg, Heidelberg

69495

Centre Hospitalier Lyon Sud, Pierre-Bénite

72076

Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Abteilung fuer Innere Medizin II,, Tübingen

86000

CHU Poitiers - Hopital la Miletrie, Poitiers

91010

City of Hope, Duarte

94143

University of California San Francisco, San Francisco

97080

Universitatsklinikum Wurzburg, Würzburg

100034

Peking University First Hospital, Beijing

110134

Shengjing Hospital Of China Medical University, Shenyang

200003

Shanghai Changzheng Hospital, Shanghai

310003

First affiliated Hospital of Zhejiang University, Hangzhou

510060

Sun Yat -Sen University Cancer Center, Guangzhou

610041

West China Hospital Si Chuan University, Chengdu

710004

The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an

94305-5623

Stanford University Medical Center, Stanford

T2N 5G2

Arthur J E Child Comprehensive Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

M5G 2M9

University Health Network UHN Princess Margaret Cancer Centre, Toronto

H4A 3J1

McGill University Health Centre, Montreal

04103

Universitaetsklinikum Leipzig, Leipzig

1081 HV

VU Medisch Centrum, Amsterdam

08916

Hosp. Univ. Germans Trias I Pujol, Badalona

08036

Hosp Clinic de Barcelona, Barcelona

413 45

Sahlgrenska University Hospital, Gothenburg

221 85

Skane University Hospital, Lund

SE-141 86

Haematology Centre, R 51, Stockholm

NW1 2PG

University College Hospital, London

SO16 6YD

University Hospital Southampton, Sothampton

SM2 5PT

Royal Marsden Hospital, Sutton

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY